Lindbrook Capital, LLC

SEC CIK: 0001767045
Latest filing: May 5, 2025

SEC filings (opens in a new tab)

PRLD holding history

Prelude Therapeutics Inc in every 13F filed by Lindbrook Capital, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

PRLD overview All 13F holders of PRLD Full Q1 2025 holdings

Shares (Q2 2022): 0; Sold out in Q2 2022
Value: $0
% of portfolio: 0.0%
Quarters held: 2; Since Q4 2021

Holdings of PRLD by Lindbrook Capital, LLC, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2022	0	$0	0.0%	−1,562−100.0%	Sold out	Holders
Q1 2022	1,562	$11.0K	<0.1%	+1,471+1,616.5%	Added	Holders
Q4 2021	91	$1.00K	<0.1%	+91	New	Holders